Skip to main content

Closed

ABOS: Acumen Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-96.5%

Financially safe

Stretched

Debt / equity0.36×

Interest coverage-26.8×

Current ratio4.55×

Acumen Pharmaceuticals, Inc.

ABOSNASDAQ Global Select·USD·Closed

Acumen Pharmaceuticals, Inc.

ABOSNASDAQ·USD·Closed

$2.15

−0.92%

$2.15

−$0.02 (0.92%)

52W Range

40thpctl

Volume

0.57×avg

Mkt Cap

155.29MUSD

P/E

-1.1TTM

Div Yield

–ann

52W Range

40thpctl

Volume

0.57×avg

Market Cap

155.29MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings